Re Advisers »

Krystal Biotech shares owned by Re Advisers

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Re Advisers from 13F filings

Historical chart of Re Advisers investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Re Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Re Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 5.5k 371.67

More positions owned by Re Advisers

JPMorgan Chase & Co. (JPM)
Lam Research Corp Com New (LRCX)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Abbvie (ABBV)
Parker-Hannifin Corporation (PH)
Alphabet Cap Stk Cl C (GOOG)
Deere & Company (DE)
UnitedHealth (UNH)
Goldman Sachs (GS)
Amazon (AMZN)
Cisco Systems (CSCO)
Eaton Corp SHS (ETN)
Wal-Mart Stores (WMT)
Royalty Pharma Shs Class A (RPRX)

View all positions for Re Advisers

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Vestor Capital Corp
Geode Capital Management
Hood River Capital Management
Redmile Group
William Blair Investment Management
T. Rowe Price Associates
Frazier Life Sciences Management

View all funds holding Krystal Biotech